Scleroderma (PSS) is a serious disease of unknown cause characterized by excessive accumulation of collagen and other connective tissue components in skin and internal organs. There are three outstanding features involved in the pathogenesis of PSS: a) excessive collagen deposition; b) vascular abnormalities and c) alterations in humoral and cellular immunity. We will continue to investigate the role of each of these components employing state-of-the-art methods currently being used in our laboratories. We previously showed that PSS fibroblasts display increased biosynthesis of collagen and elevated levels of Types I and III procollagen mRNAs. We will extend these studies to examine the mechanisms responsible for these alterations employing in vitro transcription assays and determination of mRNA stability. In addition, we will examine the transcriptional regulation of collagen gene expression by transfection of chimeric alphal(I) procollagen-CAT gene and minigene constructs containing various deletions in the promoter and first intron regions of the gene. Transfection of these constructs into normal and PSS fibroblasts will allow to determine the elements within the gene responsible for normal regulation of expression and their interaction with transcriptional factors. These studies will yield information that may permit the identification of the levels of regulation of collagen gene expression that are abnormal in PSS. To investigate the role of immunologic alterations, we will continue our studies on the modulation of fibroblast collagen gene expression by gamma- interferon (gamma-IFN) and transforming growth factor-beta(TGFbeta) and will identify alterations in their production by PSS T cell subpopulations employing Northern hybridizations nad polymerase chain reaction amplification of reverse transcriptase-generated cDNAs. The mechanisms responsible for modulation of collagen synthesis by gamma-IFN and TGFbeta will be studied utilizing in vitro transcription and transient transfection experiments and by the identification of gamma-IFN and TGBbeta-induced transcriptional factors. To study the mechanisms involved in PSS vascular alterations we will examine the effect of gamma-IFN, TGFbeta and T cell products on microvascular endothelial cells. It is expected that this comprehensive approach will give further insight into the pathogenesis and possible treatment of this incurable disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR019616-18
Application #
2078426
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1987-09-01
Project End
1996-03-31
Budget Start
1994-07-01
Budget End
1996-03-31
Support Year
18
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Kumar, S; Singh, J; Rattan, S et al. (2017) Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis. Aliment Pharmacol Ther 45:883-898
Wermuth, Peter J; Carney, Kellan R; Mendoza, Fabian A et al. (2017) Endothelial cell-specific activation of transforming growth factor-? signaling in mice induces cutaneous, visceral, and microvascular fibrosis. Lab Invest 97:806-818
Jimenez, Sergio A; Piera-Velazquez, Sonsoles (2016) Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Matrix Biol 51:26-36
Mendoza, Fabian A; Piera-Velazquez, Sonsoles; Farber, John L et al. (2016) Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis Rheumatol 68:210-7
Piera-Velazquez, Sonsoles; Mendoza, Fabian A; Jimenez, Sergio A (2016) Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases. J Clin Med 5:
Mendoza, Fabian A; Mansoor, Maryah; Jimenez, Sergio A (2016) Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives. Expert Opin Orphan Drugs 4:31-47
Mendoza, F A; Bai, R; Kebede, A G et al. (2016) Severe eosinophilic fasciitis: comparison of treatment with d-penicillamine plus corticosteroids vs. corticosteroids alone. Scand J Rheumatol 45:129-34
Londin, Eric; Loher, Phillipe; Telonis, Aristeidis G et al. (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112:E1106-15
Piera-Velazquez, Sonsoles; Jimenez, Sergio A (2015) Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis. Curr Rheumatol Rep 17:473
Piera-Velazquez, Sonsoles; Makul, Alma; Jiménez, Sergio A (2015) Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor ?. Arthritis Rheumatol 67:2749-58

Showing the most recent 10 out of 61 publications